SCHEMBL5968403

SCHEMBL5968403

N#CC(CC(N)=O)C(N)=O

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11628782 0.83 MCL1 (0.39) MCL1
SCHEMBL28880756 0.77 MCL1 (0.36) MCL1
SCHEMBL11842620 0.76 ALOX15 (0.41) MCL1
SCHEMBL28289211 0.76 TSHR (0.36)
SCHEMBL319578 0.75
SCHEMBL28250881 0.75
SCHEMBL28773374 0.75
SCHEMBL10500307 0.75 MCL1 (0.36) MCL1
SCHEMBL7431413 0.74
SCHEMBL3917719 0.73 SLC7A5 (0.39) MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060094682-A1 Kinase inhibitors for the treatment of diabetes and obesity ODYSSEY THERA, INC. (US) 2006-05-04 US disclosed
EP-0645379-B1 Benzoylacetylene derivatives MITSUBISHI CHEM CORP (JP) 1999-03-17 EP disclosed
US-5618829-A SUPPRESSION GROWTH OF CANCER CELLS MITSUBISHI CHEMICAL CORPORATION (JP) 1997-04-08 US disclosed
EP-0645379-A2 Benzoylacetylene derivatives Mitsubishi Chemical Corporation (JP) 1995-03-29 EP disclosed
EP-0608897-A2 Tyrosine kinase inhibitors and benzoylacrylamide derivatives Mitsubishi Chemical Corporation (JP) 1994-08-03 EP disclosed